Color Doppler Ultrasonography in Prediction of Arteriovenous Fistula Maturation in Hemodialysis Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03171701|
Recruitment Status : Not yet recruiting
First Posted : May 31, 2017
Last Update Posted : June 8, 2017
|Condition or disease|
Ultrasound is the main method of diagnostic imaging, because of its low cost, noninvasive without ionizing radiation associated or iodized contrast.
Vascular procedures and their complications represent a major cause of morbidity hospitalization and cost for patients in hemodialysis .
Many fistulas do not mature appropriately for being used in dialysis. So,The early recognition through the ultrasound examination of problems in the arteriovenous fistula maturation or possible complications that may compromise their viability, offers the opportunity of correction or appropriate treatment .
Criteria for maturation after arteriovenous fistula creation:
- Vein diameter larger than 4 mm remote from the site of fistula.
- Vein located at a depth of <5 mm from skin surface.
|Study Type :||Observational|
|Estimated Enrollment :||30 participants|
|Official Title:||Role of Color Doppler Ultrasonography in Prediction of Arteriovenous Fistula Maturation and Its Complications in Hemodialysis Patients|
|Estimated Study Start Date :||July 1, 2017|
|Estimated Primary Completion Date :||July 1, 2018|
|Estimated Study Completion Date :||October 1, 2018|
|maturation of arteriovenous fistula|
- Role of color Doppler ultrasonography in prediction of arteriovenous fistula maturation and its complications in hemodialysis patients [ Time Frame: one month ]Assess and monitor the maturation of the newly placed Arteriovenous fistulas, and to provide timely interventions for AV fistulas which are failing to mature
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03171701
|Contact: Hossam Abu Zeid, A. Professor||00201063602906||Hosameldeen68@gmail.com|
|Contact: Mohammed Zidan, A. Professor||00201001121365||Mzidan74@yahoo.com|